MA
MediPal Holdings Corporation
MAHLY · OTC
$18.75 +0.54% (+$0.10)
1M +2.16%
Market Cap ¥604.0B
P/E Ratio 12.75x
Div. Yield 1.73%
ROE 7.38%
Bulios Fair Price
$22.24
18.6% upside
Current Price
$18.75
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MAHLY is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
96 /100
Cheap P/E 12.75x
PEG 1.12x
EV/EBITDA 3.54x
Growth
63 /100
Stable EPS growth 6.91%
Book val. growth 5.28%
Rev. growth 6.40%
Profitability
6 /100
Weak Gross margin 6.43%
FCF margin 0.00%
Net margin 1.21%
Quality
37 /100
Average ROIC 4.12%
Asset turnover 2.04x
ROE 7.38%
Debt
94 /100
Low Debt/Equity 0.07x
Net debt/EBITDA -2.42x
Current ratio 1.29x
Stability
88 /100
Stable Beta -0.02x
Profitable years 6
Rev. volatility 3.57%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MAHLY
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Shuichi Watanabe
Employees
13,024
Headquarters
Tokyo
Upcoming events
29 SEP
Ex-Dividend
Ex-dividend date
02 DEC
Dividend Payment
Payment date